25 studies found for:
" June 27, 2007":" July 27, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 |
Completed
Has Results |
Two Approaches to Routine HIV Testing in a Hospital Emergency Department
|
||||
| 2 | Completed |
Aripiprazole Treatment for Methamphetamine Dependence Among High-risk Individuals
|
||||
| 3 | Completed |
Mirtazapine to Reduce Methamphetamine Use Among MSM With High-risk HIV Behaviors
|
||||
| 4 | Completed |
Phase I Safety and Immunogenicity Vaccine Trial Against HIV/AIDS
|
||||
| 5 | Completed |
Fanconi Syndrome Due to ARVs in HIV-Infected Persons
|
||||
| 6 | Unknown † |
Effects of HIV and Hepatitis C Virus on the Brain
|
||||
| 7 | Completed |
Kaletra Monotherapy in HIV/HCV Co-infected Subjects
|
||||
| 8 | Unknown † |
HIV Prevention in Haitian American Adolescents
|
||||
| 9 | Unknown † |
Therapeutic Schools: Affect Management and HIV Prevention
|
||||
| 10 | Unknown † |
HIV Prevention for Youth With Severe Mental Illness
|
||||
| 11 | Withdrawn |
Safety and Effectiveness of an HIV DNA Vaccine Followed by an HIV Adenoviral Vector Vaccine for Prevention of HIV Infection in the Americas and Africa
|
||||
| 12 | Unknown † |
The Effect of Malaria on Disease Progression of HIV/AIDS
|
||||
| 13 | Unknown † |
Correlation Between Cytokines and Hepatic Histology in Patients Infected by HIV-1 and the Hepatitis-C Virus
|
||||
| 14 | Completed |
Management of Hepatitis C in HIV-Infected and Uninfected IDUs
|
||||
| 15 | Active, not recruiting |
Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression
|
||||
| 16 | Completed |
Reducing Ethnic Health Disparities: Motivating HIV+ Latinos to Quit Smoking
|
||||
| 17 | Active, not recruiting |
Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO)
|
||||
| 18 | Terminated |
Safety and Efficacy Study of KP-1461 to Treat ART-Experienced HIV+ Patients
|
||||
| 19 |
Completed
Has Results |
HIV Testing Strategies in the Perinatal Setting
|
||||
| 20 | Completed |
Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus
|
† Indicates status has not been verified in more than two years
